CS241032B2 - Method of 1,2,4-oxadiazoline-5-on's new derivatives production - Google Patents

Method of 1,2,4-oxadiazoline-5-on's new derivatives production Download PDF

Info

Publication number
CS241032B2
CS241032B2 CS806737A CS673780A CS241032B2 CS 241032 B2 CS241032 B2 CS 241032B2 CS 806737 A CS806737 A CS 806737A CS 673780 A CS673780 A CS 673780A CS 241032 B2 CS241032 B2 CS 241032B2
Authority
CS
Czechoslovakia
Prior art keywords
carbon atoms
phenyl
hydroxypropyl
alkoxy
oxadiazolin
Prior art date
Application number
CS806737A
Other languages
Czech (cs)
English (en)
Other versions
CS673780A2 (en
Inventor
Kalman Takacs
Ilona Kiss
Antal Simay
Nagy P Literati
Maria Hetyey
Marian Ecsery
Laszlo Szekeres
Gyula Papp
Sandor Viragh
Eva Udvardy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CS673780A2 publication Critical patent/CS673780A2/cs
Publication of CS241032B2 publication Critical patent/CS241032B2/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CS806737A 1979-10-11 1980-10-06 Method of 1,2,4-oxadiazoline-5-on's new derivatives production CS241032B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79CI1973A HU179951B (en) 1979-10-11 1979-10-11 Process for preparing 1,2,4-oxadiazolin-5-one derivatives and pharmaceutical compositions containing thereof

Publications (2)

Publication Number Publication Date
CS673780A2 CS673780A2 (en) 1985-06-13
CS241032B2 true CS241032B2 (en) 1986-03-13

Family

ID=10994764

Family Applications (1)

Application Number Title Priority Date Filing Date
CS806737A CS241032B2 (en) 1979-10-11 1980-10-06 Method of 1,2,4-oxadiazoline-5-on's new derivatives production

Country Status (23)

Country Link
US (1) US4365064A (de)
JP (1) JPS5661375A (de)
AT (1) AT375369B (de)
BE (1) BE885633A (de)
CA (1) CA1154019A (de)
CH (1) CH649547A5 (de)
CS (1) CS241032B2 (de)
DD (1) DD153550A5 (de)
DE (1) DE3037432A1 (de)
DK (1) DK149854C (de)
ES (1) ES8106725A1 (de)
FI (2) FI71318C (de)
FR (1) FR2467203A1 (de)
GB (1) GB2059967B (de)
HU (1) HU179951B (de)
IL (1) IL61175A (de)
IT (1) IT1129305B (de)
NL (1) NL8005586A (de)
NO (1) NO154795C (de)
PL (3) PL132131B1 (de)
SE (1) SE452158B (de)
SU (1) SU1087519A1 (de)
YU (1) YU41738B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives
NZ521792A (en) * 2000-03-20 2004-06-25 N Gene Res Lab Inc Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and use in treating conditions connected with oxygen deficiency
EP3406607A1 (de) 2012-12-21 2018-11-28 Epizyme, Inc. Prmt5-inhibitoren mit einem dihydro- oder tetrahydroisochinolin und verwendungen davon
UA118548C2 (uk) 2012-12-21 2019-02-11 Епізайм, Інк. Тетрагідро- та дигідроізохіноліни як інгібітори prmt5 та їх застосування
CA2894157A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
JP2016505000A (ja) 2012-12-21 2016-02-18 エピザイム,インコーポレイティド Prmt5阻害剤およびその使用
US9611257B2 (en) 2012-12-21 2017-04-04 Epizyme, Inc. PRMT5 inhibitors and uses thereof
EP3177288A4 (de) 2014-08-04 2018-04-04 Epizyme, Inc. Prmt5-inhibitoren und verwendungen davon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (de) * 1967-12-07 1969-07-25
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives

Also Published As

Publication number Publication date
NO803044L (no) 1981-04-13
DK149854B (da) 1986-10-13
CH649547A5 (de) 1985-05-31
GB2059967A (en) 1981-04-29
HU179951B (en) 1983-01-28
PL132131B1 (en) 1985-02-28
PL232292A1 (de) 1982-04-26
YU259480A (en) 1984-02-29
IT1129305B (it) 1986-06-04
PL131451B1 (en) 1984-11-30
DK429780A (da) 1981-04-12
PL232293A1 (de) 1982-04-26
PL227209A1 (de) 1981-12-11
CA1154019A (en) 1983-09-20
FI71932C (fi) 1987-03-09
FI71932B (fi) 1986-11-28
NO154795C (no) 1986-12-29
IT8068555A0 (it) 1980-10-09
DD153550A5 (de) 1982-01-13
IL61175A (en) 1984-08-31
FI803219L (fi) 1981-04-12
NL8005586A (nl) 1981-04-14
AT375369B (de) 1984-07-25
SU1087519A1 (ru) 1984-04-23
FR2467203A1 (fr) 1981-04-17
ES495819A0 (es) 1981-09-16
GB2059967B (en) 1983-06-02
JPS5661375A (en) 1981-05-26
DE3037432A1 (de) 1981-05-27
FR2467203B1 (de) 1985-03-22
YU41738B (en) 1987-12-31
ATA501380A (de) 1983-12-15
DK149854C (da) 1987-04-21
FI71318C (fi) 1986-12-19
FI71318B (fi) 1986-09-09
CS673780A2 (en) 1985-06-13
BE885633A (fr) 1981-02-02
US4365064A (en) 1982-12-21
NO154795B (no) 1986-09-15
SE452158B (sv) 1987-11-16
SE8007025L (sv) 1981-04-12
PL131375B1 (en) 1984-11-30
FI803220L (fi) 1981-04-12
ES8106725A1 (es) 1981-09-16
IL61175A0 (en) 1980-11-30

Similar Documents

Publication Publication Date Title
EP0094159B1 (de) Dihydropyridinderivate, deren Herstellung und Verwendung
JP2651043B2 (ja) ジフェニルメチルピペラジン誘導体
EP0424525B1 (de) Amine und deren verwendung
EP0060674A1 (de) Dihydropyridine als anti-ischämische und antihypertensive Mittel, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0116769B1 (de) Dihydropyridine
RU2036922C1 (ru) Производные 1,4-дигидропиридина или их гидрохлориды, обладающие антагонистическими свойствами по отношению к ионам кальция
JPH04230681A (ja) 1,4‐ベンゾチアゼピン誘導体
EP0106462B1 (de) Dihydropyridine
NO156525B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
US4535073A (en) Antihypertensive phosphono derivatives of hantzsch dihydropyridines
US4992447A (en) Certain oxo-pyrrolo 1,4-dihydropyridines as antiallergy and antiinflammatory agents
CS241032B2 (en) Method of 1,2,4-oxadiazoline-5-on's new derivatives production
NZ223383A (en) 3,4-dihydro-2h-benzopyrans and pharmaceutical compositions
US4560686A (en) Method for treating circulatory diseases by using (2-lower alkoxyphenyl)piperazine derivatives
HU189599B (en) Process for producing amidobenzamide derivatives and pharmaceutical compositions containing them
JPH05271208A (ja) 1,4‐ベンゾチアゼピン誘導体
US5064850A (en) Dihydro-3,3-diphenyl-5-(1H-pyrazol-1-ylmethyl-2(3H)-furanone and dihydro-5-((substituted-1H-pyrazol-1-yl)methyl)-3,3-diphenyl-2(3H)-furanone derivatives
JPS6256474A (ja) ジヒドロピリジン−2−ヒドロキシアミン類
EP0532629B1 (de) Derivate des 1-piperidinyl-alkanoylarylsulfonamids
US4638003A (en) 1-(4-alkylthiophenyl)-2-(substituted or unsubstituted piperazine-1-yl)-1,3-propanediol, pharmaceutical compositions containing them useful as antiarrhythmic and vasodilating agents
JPS60158190A (ja) ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
US5116851A (en) Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides
US4891373A (en) Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
US3989708A (en) 2-Amino-1,4-dihydropyridine derivatives
JPH03148284A (ja) ジヒドロピリミドチアジン誘導体、それを主成分とする抗炎症剤等製剤組成物、その製造の際の中間体、およびそれらの製造方法